Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (4): 62-69.doi: 10.6040/j.issn.1673-3770.0.2023.485
• Original Article • Previous Articles
ZHANG Lin, XIN Yunchao, SHANG Xiaoling, XIE Qi, LIU Yachao
CLC Number:
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi:10.3322/caac.21660 [2] 李静静, 武欣欣, 毛宁, 等. 基于CT影像组学诺模图术前预测甲状腺乳头状癌颈部中央区淋巴结转移的研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 51-59. doi:10.6040/j.issn.1673-3770.0.2020.490 LI Jingjing, WU Xinxin, MAO Ning, et al. CT-based radiomics nomogram for the preoperative prediction of central lymph node metastases of papillary thyroid carcinoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2021, 35(4): 51-59. doi:10.6040/j.issn.1673-3770.0.2020.490 [3] Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133. doi:10.1089/thy.2015.0020 [4] 薛峰, 姜雪. 临床淋巴结阴性甲状腺乳头状微小癌与非微小癌的超声特征对比研究[J]. 中国医师进修杂志, 2021, 44(9): 801-804. doi:10.3760/cma.j.cn115455-20200528-00672 XUE Feng, JIANG Xue. Comparative study on sonographic features of clinical lymph node negative papillary thyroid microcarcinoma and non-microcarcinoma[J]. Chinese Journal of Postgraduates of Medicine, 2021, 44(9): 801-804. doi:10.3760/cma.j.cn115455-20200528-00672 [5] 武元元, 王军, 毛爱红, 等. 甲状腺微小乳头状癌颈中央区淋巴结转移评分系统的初步建立[J]. 中国耳鼻咽喉头颈外科, 2021, 28(11): 661-663. doi:10.16066/j.1672-7002.2021.11.001 WU Yuanyuan, WANG Jun, MAO Aihong, et al. Preliminary establishment of a scoring system for predicting cervical central lymph node metastasis in papillary thyroid microcarcinoma[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2021, 28(11): 661-663. doi:10.16066/j.1672-7002.2021.11.001 [6] Kim BY, Choi N, Kim SW, et al. Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma[J]. Eur Arch Otorhinolaryngol, 2020, 277(2): 569-576. doi:10.1007/s00405-019-05702-3 [7] 薛刚, 孙新民, 林旭, 等. KCNK5双孔钾通道蛋白在甲状腺乳头状癌中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 64-69. doi:10.6040/j.issn.1673-3770.0.2021.004 XUE Gang, SUN Xinmin, LIN Xu, et al. Expression and clinical significance of the KCNK5 double-pore potassium channel protein in papillary thy-roid carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 64-69. doi:10.6040/j.issn.1673-3770.0.2021.004 [8] 祝嘉, 秦晓茹, 郝玲玲, 等. 甲状腺微小乳头状癌预后影响因素与治疗进展[J]. 中国医药导刊, 2021, 23(12): 907-911. doi: 10.3969/j.issn.1009-0959.2021.12.007 ZHU Jia, QIN Xiaoru, HAO Lingling, et al. Prognostic factors and treatment progress of papillary thyroid microcarcinoma[J]. Chinese Journal of Medicinal Guide, 2021, 23(12): 907-911. doi: 10.3969/j.issn.1009-0959.2021.12.007 [9] 刘兰侠, 刘杜先. 甲状腺乳头状癌亚型的临床病理特点及术后复发的影响因素分析[J]. 药物生物技术, 2020, 27(5): 462-466. doi:10.19526/j.cnki.1005-8915.20200515 LIU Lanxia, LIU Duxian. Analysis on the clinicopathologic features of thyroid papillary carcinoma subtype and the influencing factors of postoperative recurrence[J]. Pharmaceutical Biotechnology, 2020, 27(5): 462-466. doi:10.19526/j.cnki.1005-8915.20200515 [10] Filetti S, Durante C, Hartl D, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2019, 30(12): 1856-1883. doi:10.1093/annonc/mdz400 [11] 王晨, 张国梁, 张守亮. 甲状腺微小乳头状癌颈部中央区淋巴结转移相关因素分析[J]. 中国现代普通外科进展, 2020, 23(10): 821-822. doi:10.3969/j.issn.1009-9905.2020.10.016 WANG Chen, ZHANG Guoliang, ZHANG Shouliang. Analysis of related factors of lymph node metastasis in central cervical region of papillary thyroid carcinoma[J]. Chinese Journal of Current Advances in General Surgery, 2020, 23(10): 821-822. doi:10.3969/j.issn.1009-9905.2020.10.016 [12] 张莉, 王燕红, 丰荣红. 超声定量技术联合血清微小RNA-599及半乳糖凝集素-3在甲状腺乳头状癌颈部淋巴结转移中的应用研究[J]. 中国医师进修杂志, 2022, 45(12): 1142-1146. doi:10.3760/cma.j.cn115455-20211113-01324 ZHANG Li, WANG Yanhong, FENG Ronghong. Application of ultrasound quantitative technique combined with serum microRNA-599 and galectin-3 in cervical lymph node metastasis of papillary thyroid carcinoma[J]. Chinese Journal of Postgraduates of Medicine, 2022, 45(12): 1142-1146. doi:10.3760/cma.j.cn115455-20211113-01324 [13] 王金秋, 张立, 章佳波, 等. 甲状腺乳头状微小癌cN0期中央区淋巴结转移相关因素分析[J]. 中华内分泌外科杂志, 2020, 14(4): 279-283. doi:10.3760/cma.j.issn.115807-20191103-00213 WANG Jinqiu, ZHANG Li, ZHANG Jiabo, et al. Related risk factors of central lymph node metastasis in papillary thyroid microcarcinoma of CN0 stage[J]. Chinese Journal of Endocrine Surgery, 2020, 14(4): 279-283. doi:10.3760/cma.j.issn.115807-20191103-00213 [14] 陈皖肖, 倪忠鹏, 崔怀信. cN0期甲状腺乳头状癌中央区淋巴结转移的危险因素分析[J]. 中国普外基础与临床杂志, 2021, 28(4): 488-492. doi:10.7507/1007-9424.202006084 CHEN Wanxiao, NI Zhongpeng, CUI Huaixin. Analysis of risk factors for central lymph node metastasis in CN0 papillary thyroid carcinoma[J]. Chinese Journal of Bases and Clinics in General Surgery, 2021, 28(4): 488-492. doi:10.7507/1007-9424.202006084 [15] 陆一丹, 时开元, 欧笛, 等. 甲状腺微小癌预后风险评估与治疗决策的研究进展[J]. 中国肿瘤, 2020, 29(12): 962-969. doi:10.11735/j.issn.1004-0242.2020.12.A013 LU Yidan, SHI Kaiyuan, OU Di, et al. Progress on prognostic risk assessment and treatment strategy for thyroid microcarcinoma[J]. China Cancer, 2020, 29(12): 962-969. doi:10.11735/j.issn.1004-0242.2020.12.A013 [16] Chen ZD, Ruan JY, Yao YJ, et al. A comparison of the seventh and eighth editions of the AJCC staging systems to predict recurrence in papillary thyroid microcarcinoma[J]. Ann Surg Oncol, 2021, 28(11): 6564-6571. doi:10.1245/s10434-021-09596-6 [17] Song JL, Yan T, Qiu WW, et al. Clinical analysis of risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a retrospective study of 3686 patients[J]. Cancer Manag Res, 2020, 12: 2523-2530. doi:10.2147/CMAR.S250163 [18] Park JP, Roh JL, Lee JH, et al. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma[J]. Am J Surg, 2014, 208(3): 412-418. doi:10.1016/j.amjsurg.2013.10.032 [19] Back K, Kim JS, Kim JH, et al. Superior located papillary thyroid microcarcinoma is a risk factor for lateral lymph node metastasis[J]. Ann Surg Oncol, 2019, 26(12): 3992-4001. doi:10.1245/s10434-019-07587-2 [20] 黄春, 邓畅, 苏新良. cN0甲状腺微小乳头状癌淋巴结转移的危险因素分析[J]. 中国普外基础与临床杂志, 2021, 28(7): 888-891. doi:10.7507/1007-9424.202009040 HUANG Chun, DENG Chang, SU Xinliang. Risk factors of lymph node metastasis in papillary thyroid microcarcinoma with CN0[J]. Chinese Journal of Bases and Clinics in General Surgery, 2021, 28(7): 888-891. doi:10.7507/1007-9424.202009040 |
[1] | WANG Jingsong, YU Can, ZHANG Xi, DENG Qicheng, XIE Zhuoliang, ZHAO Rui, WEN Bei, LIU Hai. Expression and clinical significance of KRT4 in laryngeal carcinoma and adjacent normal mucosal tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 12-17. |
[2] | XIE Yulin, LEI Dapeng. Advances in the pathological study of artificial intelligence in the lymph node metastasis of head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 124-129. |
[3] | MENG Sukun, ZHANG Chun. Long-term progress of visual field defect for open-angle glaucoma patients with ab interno trabeculotomy with the trabectome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 139-148. |
[4] | LI Lu, ZHAO Jie, ZHAO Bojun. Research progress on the pathogenesis and treatments of central serous chorioretinopathy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 118-124. |
[5] | LI Zhilin, ZHENG Zhou, AN Wei. Clinical and survival analysis of primary squamous cell carcinoma of the thyroid 12 cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 59-63. |
[6] | XIAO Fuliang, LIN Yun, PAN Xinliang. A clinical study on prophylactic central lymph node dissection in early cN0 papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 64-71. |
[7] | LI Aijun, CUI Xiaomei. Current status of comprehensive pathway management atrial fibrillation before cataract surgery: a cross-sectional survey [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 38-44. |
[8] | CHEN Dongyan, QIAN Ye, WEI Dongmin, LI Wenming, XIA Tongliang, LEI Dapeng, PAN Xinliang. Clinical value of high-frequency ultrasound in the diagnosis of lymph node metastasis in hypopharyngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 18-23. |
[9] | ZHANG Lijun, XU Ran, LUO Jifang, LIU Guoqi, HE Qian, LI Wei, JIANG Zhenhua. Factors affecting flap neurosis and other postoperative flap-related complications after free-flap reconstruction of head and neck tumors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 86-90. |
[10] | LIU Shanshan, HAN Shujing, WANG Xiaoxu, LI Yanhong, NI Xin, ZHANG Jie. Hearing loss in children after bacterial meningitis: a systematic review and meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 48-54. |
[11] | LI Jingjing, WU Xinxin, MAO Ning, ZHENG Guibin, MU Yakui, CHU Tongpeng, JIA Chuanliang, ZHENG Haitao, MI Jia, SONG Xicheng. CT-based radiomics nomogram for the preoperative prediction of central lymph node metastases of papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 51-59. |
[12] | PANG Zhenwen, HUANG Yufeng, YANG Aifang, ZENG Xianjie. Correlation between Preoperative neutrophil/lymphocyte ratio and lymph node metastasis in patients with laryngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 58-62. |
[13] | To describe characteristics and risk factors associated with central serous chorioretinopathy(CSC)in a hospital-based outpatient sample population. MethodsIn this hospital-based cross-sectional study, CSC patients were recruited from the Beijing Friendship Hospital from 01/2019 to 12/2019. All participants underwent a standardized interview. Logistic regression models were used to assess the risk factors associated with CSC. ResultsA total of 23,878 outpatients were recorded during the period 01/2019-12/2019. Of these, 45 patients(0.19%)were diagnosed with CSC, divided in 37 male patients(82.22%)and 8 female patients(17.78%). The patients′ age ranged from 21 to 65(42.3±10.1)years. Three patients(6.67%)presented a bilateral involvement. Of all the patients, 39 were included in the present analysis. Control patients were matched for age and sex at a ratio of 1:1. The presence of CSC was associated with exposure to steroids(OR=5.04, 95% CI:1.11-22.89), sleep time(going to sleep after 12 pm)(OR=4.16, 95% CI:1.33-13.04)),and shift-work(OR=5.74, 95% CI:1.47-22.45).ConclusionsOur data showed that CSC prevalence in the analyzed outpatients was 0.19%. Exposure to steroids, sleep time, and shift-work were factors related with CSC in the observed population.. Prevalence and risk factors of central serous chorioretinopathy in a hospital-based population YANG Xiufen, YOU Ran, MA Xiumei, WANG Kang, WANG Yanling Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract:Objective〓 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 75-79. |
[14] | This study was conducted to explore the preoperative risk factors for postoperative adhesion in patients with chronic rhinosinusitis(CRS)undergoing functional endoscopic sinus surgery(FESS), and to construct a risk score model to evaluate their predictive effect. MethodsA retrospective study was conducted on 323 patients with CRS who underwent FESS at our hospital between January 2015 and June 2018. The risk factors for postoperative adhesion were screened using a multivariate logistic regression analysis. The risk score was assigned according to the odds ratio(OR)value, and a receiver operating characteristic(ROC)curve was drawn to evaluate the predictive effect. ResultsPostoperative adhesion occurred in 35 patients(10.8%). The logistic regression results showed that concha bullosa, primary FESS, operative experience less than 10 years, and a history of middle turbinate resection were independent risk factors for postoperative adhesion in FESS. The OR values were 1.12(95% CI: 1.06-1.18), 3.87(95% CI: 2.23-5.51), 3.19(95% CI: 2.07-4.31), and 2.24(95% CI:1.95-2.53), respectively. The risk score model assigned 1 point for vesicular middle turbinate, 4 points for first time FESS, 3 points for operative experience less than 10 years, and 2 points for middle turbinate resection. The ROC curve analysis showed that the area under the curve(AUC)was 0.784(95% CI: 0.672-0.896, P<0.05). When 4 points were selected as the cut-off point, the Jordan index was the largest, with a sensitivity of 75.1% and a specificity of 73.6%. ConclusionThe incidence of postoperative adhesion in 323 patients with CRS who underwent FESS was 10.8%. The risk score model has certain reference value for predicting high-risk postoperative adhesion.. Potential risk factors and evaluation of a predictive risk score model for postoperative adhesion in functional endoscopic sinus surgeryCHEN Dong1, YU Hong2, LI Yang1, HUANG Qiang1, FANG Min1 1. Department of Otolaryngology, Jiangyou Peoples Hospital, Jiangyou 621700, Sichuan, China; 2. Department of Pathology, Jiangyou Peoples Hospital, Jiangyou 621700, Sichuan, ChinaAbstract:Objective〓 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 87-91. |
[15] | CHEN Haibing, WEI Ya'nan, XU Xiaoquan, CHEN Xi. Prediction of cervical lymph node metastasis in papillary thyroid cancer based on XGBoost artificial intelligence and enhanced computed tomography [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 40-45. |
|